vTv Therapeutics VTVT
NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Short-Term Debt issuances (2017)

vTv Therapeutics' (VTVT) quarterly Short-Term Debt issuances came in at $7.5 million in Q1 2017.

Analysis

vTv Therapeutics (VTVT) Short-Term Debt issuances (2017) Analysis & Trends

vTv Therapeutics has disclosed Short-Term Debt issuances across 1 years of filings, most recently posting $7.5 million for Q1 2017.

  • In Q1 2017, Short-Term Debt issuances changed N/A year-over-year to $7.5 million; the TTM figure through Dec 2017 stood at $7.5 million (changed N/A YoY), while the FY2017 annual figure was $7.5 million, down 40.0% from the prior year.
  • Short-Term Debt issuances came in at $7.5 million for Q1 2017 at vTv Therapeutics.
  • In the past five years, Short-Term Debt issuances ranged from a high of $7.5 million in Q1 2017 to a low of $7.5 million in Q1 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 707.00 Mn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn -
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 4.94 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 208.00 Mn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 64.00 Mn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn -
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 vTv Therapeutics 413.85 Mn 413.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 7.50 Mn